630-580-1088 sales@ambeed.com
Structure Search

List Search MOL Search Structure Search

0
Chemistry
Asymmetric Synthesis >>Chiral Building BlocksChiral Catalysts, Chiral Ligands and Chiral ReagentsChiral Resolution ReagentsBoronic acids/esters >>Aliphatic BoronsAromatic BoronsOther BoronsOxaborolesCatalysis Chemistry >>Achiral Crown LigandsC-H ActivationCarbon-Donor LigandsChiral Carbon LigandsChiral Crown LigandsChiral Olefin LigandsCross-CouplingCross-Coupling Using Transition Metal CatalystsDACH or Trost LigandsChemical Biology >>Conjugation Chemistry
GlycoscienceLinkers and CrosslinkersNucleic Acid ChemistryPEGylationPeptide ChemistryPhotolabile Protecting GroupHeterocyclic Building Blocks >>AcridinesAliphatic HeterocyclesAromatic HeterocyclesAzetidinesBenzimidazolesBenzisoxazolesBenzodioxansBenzofuransBenzothiazolesInorganic reagents >>Inorganic ReagentOrganic Building Blocks >>Acid AnhydridesAcyl Chlorides
AlcoholsAldehydesAliphatic Chain HydrocarbonsAliphatic Cyclic HydrocarbonsAlkenesAlkylsAlkynesOrganometallic Reagents >>Grignard ReagentsOrganoarsenicOrganobismuthOrganoboronOrganogermaniumOrganolithiumOrganomercuryOrganosiliconOrganotinSpecialty Synthesis >>Enzyme-Mediated SynthesisFluorous SynthesisIonic Liquids
Solid Supported SynthesisStains and Dyes >>Acid DyesAzoic DyesBasic DyesDirect DyesDisperse DyesDye IntermediatesMordant DyesOil DyesOther Stains and DyesSynthetic Reagents >>Acids and BasesC-C Bond FormationC-X Bond Formation (Halogen)C-X Bond Formation (Non-Halogen)Chelation and Complexation CompoundsCondensation AgentsCouplingDehydrating ReagentsFluorination Reagent
Pharmaceutical Intermediates
Analgesics >>BenzhydrocodoneBicifadineCapsaicinCelecoxibDebio-0827DexamethasoneElagolix SodiumEsketamine HydrochlorideIbuprofen SodiumAnesthetics >>CiprofolEsketamine HydrochlorideFospropofol Fospropofol DisodiumLevobupivacaine RemimazolamRemimazolam BesilateRemimazolam BesylateRopivacaineAnti-Addiction Agents >>Kakonein
Lofexidine HydrochlorideVarenicline Anti-inflammatory Agents >>ApremilastAsunaprevirATB-346 RelatedBalsalazide BaricitinibBencycloquidium BromideBudesonideCefiderocol Sulfate TosylateCeftaroline Fosamil AcetateAntibacterials >>AFN-1252 RelatedAlatrofloxacin Bedaquiline FumarateBesifloxacin BrilacidinCaspofungin AcetateCefiderocol Sulfate TosylateCefilavancinCeftaroline Fosamil
Anticonvulsants >>BrivaracetamCannabidiolEscitalopram OxalateEslicarbazepine Acetate RelatedFosphenytoinGabapentin EnacarbilJNJ-10234094LacosamideLevetiracetam RelatedAntidementia Agents >>Azeliragon RelatedDavunetideDonepezil HydrochlorideDonepezil RelatedEnsaculinFlorbetaben Flortaucipir F 18Flutemetamol IdalopirdineAntidepressants >>4-Chlorokynurenine
AgomelatineAgomelatine RelatedAllopregnanolone RelatedAmibegronAmitifadineAripiprazole RelatedBasimglurantBefloxatoneAntiemetics >>AprepitantAprepitant RelatedDolasetron RelatedDolasetron Mesylate HydrateFosaprepitant DimeglumineFosaprepitant RelatedOlanzapinePalonosetron RelatedPalonosetron HydrochlorideAntifungals >>Anidulafungin RelatedCabotegravirMore >>
Inhibitors/Agonists
ADC >>ADC AntibodyADC LinkerADC Linker with PayloadADC ToxinAntibody-Drug Conjugates (ADCs)Drug-Linker Conjugates for ADCAngiogenesis >>ALKBcr-AblBTKEGFRFAKFGFRFLT3HER2HIFAnti-infection >>3CLproAntibacterialAntibioticAntifungal
AntiparasiticAntiprotozoalAntiviralArenavirusBVDVApoptosis >>Apoptosis InducerBcl-2Bcl-6BRKc-Mycc-RETC/EBPCARDCaspaseAutophagy >>Atg4ATG4BATTECsAUTACsAutophagyBeclin1
FKBPLC3LRRK2Biochemical Reagent >>Cell Cycle >>AntifolateAPCAurora KinaseBUBCasein KinaseCdc25CDKChkCRISPR/Cas9Cytoskeleton >>ActinArp2/3 ComplexCYTHCytoplasmic DyneinDynaminFAKMore >>
Material Science
Aggregation-Induced Emission >>Other AIE BlocksTetraphenylethylene SeriesCOFs Linkers >>Aldehyde COFs LinkersAlkynyl COFs LinkersAmine COFs LinkersBoric COFs LinkersCyano COFs LinkersMultifunctional COFs linkersOther COFs linkersTriptycene SeriesElectronic Materials >>Battery MaterialsDye-Sensitized Solar Cell (DSSC) MaterialsElectronic MaterialLiquid Crystal (LC) MaterialsMolecular ConductorsOrganic Light-Emitting Diode (OLED) MaterialsOrganic Solar Cell (OPV) MaterialsOrganic Transistor (OFET) MaterialsPerovskite Solar Cell (PSC) MaterialsMagnetic Materials >>Magnetic Ionic LiquidsMagnetic MaterialMagnetic Metal Complexes
Organic Radicals Material Chemical Compounds >>Ligands for Functional Metal ComplexesLiquid Crystal (LC) Building BlocksPhthalocyanine Building BlocksPolymer and Macromolecule Semiconductor Building BlocksSmall Molecule Semiconductor Building BlocksSolubility Enhancing Reagents Supramolecular Host Materials MOF Ligands >>Carboxylic Acid MOF LigandsCarboxylic Acid Nitrogen-Containing Mixed MOF LigandsNitrogen-Containing MOF LigandsOther MOF LigandsNanomaterials >>Carbon NanomaterialsCeramic MembranesDendrimersGold NanoparticlesIron Oxide NanoparticlesMaterials by ApplicationMesoporous MaterialsMetals and Metal AlloysNano Minerals: NanoclaysOLED Materials >>Dopant
HostHTMOLED IntermediatesOther OLED related materialsOptical Materials >>Coumarin DyesCyanine and Squarylium DyesDCM DyesDipyrromethene DyesFluorescence MaterialsFluorescent ProbesHeat and Pressure Sensitive DyesNear-Infrared (NIR) DyesOrganic Non-Linear Optical (NLO) MaterialsOrganic Pigments >>Organic PigmentOther Materials >>Mateial OtherPolymer Science >>MonomersPolymer AdditivesPolymerization ReagentsPolymersResins
Contact Us
Home Cart 0 Sign in  
Chemistry
Heterocyclic Building Blocks
Piperidines
tert-Butyl ((4-(hydroxymethyl)piperidin-4-yl)methyl)carbamate
Chemistry
Heterocyclic Building Blocks
Organic Building Blocks
Piperidines
Amines Amides Alcohols Aliphatic Heterocycles

[ CAS No. 493026-47-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 493026-47-4
Chemical Structure| 493026-47-4
Structure of 493026-47-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 110K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 493026-47-4 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 493026-47-4 ]

SDS Specification
Alternatived Products of [ 493026-47-4 ]

Product Details of [ 493026-47-4 ]

CAS No. :493026-47-4 MDL No. :MFCD22397604
Formula : C12H24N2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 244.33 Pubchem ID :-
Synonyms :

Safety of [ 493026-47-4 ]

Signal Word: Class:
Precautionary Statements: UN#:
Hazard Statements: Packing Group:

Application In Synthesis of [ 493026-47-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 493026-47-4 ]

[ 493026-47-4 ] Synthesis Path-Downstream   1~12

  • 1
  • [ 1121-76-2 ]
  • [ 493026-47-4 ]
  • [ 493026-49-6 ]
YieldReaction ConditionsOperation in experiment
43% With sodium hydrogencarbonate In i-Amyl alcohol for 2h; Heating;
Reference： [1]Nishida, Hidemitsu; Miyazaki, Yutaka; Mukaihira, Takafumi; Saitoh, Fumihiko; Fukui, Miyuki; Harada, Kousuke; Itoh, Manabu; Muraoka, Aki; Matsusue, Tomokazu; Okamoto, Atsushi; Hosaka, Yoshitaka; Matsumoto, Miwa; Ohnishi, Shuhei; Mochizuki, Hidenori [Chemical and Pharmaceutical Bulletin, 2002, vol. 50, # 9, p. 1187 - 1194]
  • 2
  • [ 493026-45-2 ]
  • [ 493026-47-4 ]
YieldReaction ConditionsOperation in experiment
39% With hydrogen In ethanol; dichloromethane at 20℃; for 48h;
Reference： [1]Nishida, Hidemitsu; Miyazaki, Yutaka; Mukaihira, Takafumi; Saitoh, Fumihiko; Fukui, Miyuki; Harada, Kousuke; Itoh, Manabu; Muraoka, Aki; Matsusue, Tomokazu; Okamoto, Atsushi; Hosaka, Yoshitaka; Matsumoto, Miwa; Ohnishi, Shuhei; Mochizuki, Hidenori [Chemical and Pharmaceutical Bulletin, 2002, vol. 50, # 9, p. 1187 - 1194]
  • 3
  • [ 24424-99-5 ]
  • [ 493026-47-4 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: 91 percent / aq. NaOH / dioxane / 1.5 h / 60 °C 2: 39 percent / H2 / 10 percent Pd/C / ethanol; CH2Cl2 / 48 h / 20 °C
Reference： [1]Nishida, Hidemitsu; Miyazaki, Yutaka; Mukaihira, Takafumi; Saitoh, Fumihiko; Fukui, Miyuki; Harada, Kousuke; Itoh, Manabu; Muraoka, Aki; Matsusue, Tomokazu; Okamoto, Atsushi; Hosaka, Yoshitaka; Matsumoto, Miwa; Ohnishi, Shuhei; Mochizuki, Hidenori [Chemical and Pharmaceutical Bulletin, 2002, vol. 50, # 9, p. 1187 - 1194]
  • 4
  • [ 493026-47-4 ]
  • [ 493026-51-0 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: 43 percent / NaHCO3 / 3-methyl-butan-1-ol / 2 h / Heating 2: 80 percent / H2 / Raney Ni / methanol / 1 h / 20 °C
Reference： [1]Nishida, Hidemitsu; Miyazaki, Yutaka; Mukaihira, Takafumi; Saitoh, Fumihiko; Fukui, Miyuki; Harada, Kousuke; Itoh, Manabu; Muraoka, Aki; Matsusue, Tomokazu; Okamoto, Atsushi; Hosaka, Yoshitaka; Matsumoto, Miwa; Ohnishi, Shuhei; Mochizuki, Hidenori [Chemical and Pharmaceutical Bulletin, 2002, vol. 50, # 9, p. 1187 - 1194]
  • 5
  • [ 493026-47-4 ]
  • 4-(aminomethyl)-1-(4-pyridinyl)-4-piperidinemethanol dihydrochloride [ No CAS ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 3 steps 1: 43 percent / NaHCO3 / 3-methyl-butan-1-ol / 2 h / Heating 2: 80 percent / H2 / Raney Ni / methanol / 1 h / 20 °C 3: 75 percent / aq. HCl / methanol / 0.17 h / 40 °C
Reference： [1]Nishida, Hidemitsu; Miyazaki, Yutaka; Mukaihira, Takafumi; Saitoh, Fumihiko; Fukui, Miyuki; Harada, Kousuke; Itoh, Manabu; Muraoka, Aki; Matsusue, Tomokazu; Okamoto, Atsushi; Hosaka, Yoshitaka; Matsumoto, Miwa; Ohnishi, Shuhei; Mochizuki, Hidenori [Chemical and Pharmaceutical Bulletin, 2002, vol. 50, # 9, p. 1187 - 1194]
  • 6
  • [ 493026-47-4 ]
  • 4-[4-(6-chloro-naphthalene-2-sulfonyl)-2-oxo-piperazin-1-ylmethyl]-3,4,5,6-tetrahydro-2<i>H</i>-[1,4']bipyridinyl-4-carbaldehyde [ No CAS ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 5 steps 1.1: 43 percent / NaHCO3 / 3-methyl-butan-1-ol / 2 h / Heating 2.1: 80 percent / H2 / Raney Ni / methanol / 1 h / 20 °C 3.1: 75 percent / aq. HCl / methanol / 0.17 h / 40 °C 4.1: AcOH / CH2Cl2 / 1 h / 20 °C 4.2: 30 percent / NaBH(OAc)3 / CH2Cl2 / 20 °C 5.1: DMSO; (COCl)2; NEt3 / CH2Cl2 / -78 - 20 °C
Reference： [1]Nishida, Hidemitsu; Miyazaki, Yutaka; Mukaihira, Takafumi; Saitoh, Fumihiko; Fukui, Miyuki; Harada, Kousuke; Itoh, Manabu; Muraoka, Aki; Matsusue, Tomokazu; Okamoto, Atsushi; Hosaka, Yoshitaka; Matsumoto, Miwa; Ohnishi, Shuhei; Mochizuki, Hidenori [Chemical and Pharmaceutical Bulletin, 2002, vol. 50, # 9, p. 1187 - 1194]
  • 7
  • [ 493026-47-4 ]
  • [ 239071-64-8 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 4 steps 1.1: 43 percent / NaHCO3 / 3-methyl-butan-1-ol / 2 h / Heating 2.1: 80 percent / H2 / Raney Ni / methanol / 1 h / 20 °C 3.1: 75 percent / aq. HCl / methanol / 0.17 h / 40 °C 4.1: AcOH / CH2Cl2 / 1 h / 20 °C 4.2: 30 percent / NaBH(OAc)3 / CH2Cl2 / 20 °C
Reference： [1]Nishida, Hidemitsu; Miyazaki, Yutaka; Mukaihira, Takafumi; Saitoh, Fumihiko; Fukui, Miyuki; Harada, Kousuke; Itoh, Manabu; Muraoka, Aki; Matsusue, Tomokazu; Okamoto, Atsushi; Hosaka, Yoshitaka; Matsumoto, Miwa; Ohnishi, Shuhei; Mochizuki, Hidenori [Chemical and Pharmaceutical Bulletin, 2002, vol. 50, # 9, p. 1187 - 1194]
  • 8
  • [ 493026-47-4 ]
  • 4-[(6-chloro-2-naphthalenyl)sulfonyl]-1-[[4-hydroxyiminomethyl-1-(4-pyridinyl)-4-piperidinyl]methyl]-2-piperazinone [ No CAS ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 6 steps 1.1: 43 percent / NaHCO3 / 3-methyl-butan-1-ol / 2 h / Heating 2.1: 80 percent / H2 / Raney Ni / methanol / 1 h / 20 °C 3.1: 75 percent / aq. HCl / methanol / 0.17 h / 40 °C 4.1: AcOH / CH2Cl2 / 1 h / 20 °C 4.2: 30 percent / NaBH(OAc)3 / CH2Cl2 / 20 °C 5.1: DMSO; (COCl)2; NEt3 / CH2Cl2 / -78 - 20 °C 6.1: 100 mg / AcONa; HONH2*HCl / ethanol; CHCl3 / 20 °C
Reference： [1]Nishida, Hidemitsu; Miyazaki, Yutaka; Mukaihira, Takafumi; Saitoh, Fumihiko; Fukui, Miyuki; Harada, Kousuke; Itoh, Manabu; Muraoka, Aki; Matsusue, Tomokazu; Okamoto, Atsushi; Hosaka, Yoshitaka; Matsumoto, Miwa; Ohnishi, Shuhei; Mochizuki, Hidenori [Chemical and Pharmaceutical Bulletin, 2002, vol. 50, # 9, p. 1187 - 1194]
  • 9
  • [ 493026-47-4 ]
  • 4-[4-(6-chloro-naphthalene-2-sulfonyl)-2-oxo-piperazin-1-ylmethyl]-3,4,5,6-tetrahydro-2<i>H</i>-[1,4']bipyridinyl-4-carboxylic acid methyl ester [ No CAS ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 7 steps 1.1: 43 percent / NaHCO3 / 3-methyl-butan-1-ol / 2 h / Heating 2.1: 80 percent / H2 / Raney Ni / methanol / 1 h / 20 °C 3.1: 75 percent / aq. HCl / methanol / 0.17 h / 40 °C 4.1: AcOH / CH2Cl2 / 1 h / 20 °C 4.2: 30 percent / NaBH(OAc)3 / CH2Cl2 / 20 °C 5.1: DMSO; (COCl)2; NEt3 / CH2Cl2 / -78 - 20 °C 6.1: 40 mg / 2-methyl-2-butene; aq. NaClO2; NaH2PO4 / 2-methyl-propan-2-ol; CHCl3 / 20 °C 7.1: 44 percent / methanol; CH2Cl2; hexane / 2 h / 20 °C
Reference： [1]Nishida, Hidemitsu; Miyazaki, Yutaka; Mukaihira, Takafumi; Saitoh, Fumihiko; Fukui, Miyuki; Harada, Kousuke; Itoh, Manabu; Muraoka, Aki; Matsusue, Tomokazu; Okamoto, Atsushi; Hosaka, Yoshitaka; Matsumoto, Miwa; Ohnishi, Shuhei; Mochizuki, Hidenori [Chemical and Pharmaceutical Bulletin, 2002, vol. 50, # 9, p. 1187 - 1194]
  • 10
  • [ 493026-47-4 ]
  • [ 239071-65-9 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 6 steps 1.1: 43 percent / NaHCO3 / 3-methyl-butan-1-ol / 2 h / Heating 2.1: 80 percent / H2 / Raney Ni / methanol / 1 h / 20 °C 3.1: 75 percent / aq. HCl / methanol / 0.17 h / 40 °C 4.1: AcOH / CH2Cl2 / 1 h / 20 °C 4.2: 30 percent / NaBH(OAc)3 / CH2Cl2 / 20 °C 5.1: DMSO; (COCl)2; NEt3 / CH2Cl2 / -78 - 20 °C 6.1: 40 mg / 2-methyl-2-butene; aq. NaClO2; NaH2PO4 / 2-methyl-propan-2-ol; CHCl3 / 20 °C
Reference： [1]Nishida, Hidemitsu; Miyazaki, Yutaka; Mukaihira, Takafumi; Saitoh, Fumihiko; Fukui, Miyuki; Harada, Kousuke; Itoh, Manabu; Muraoka, Aki; Matsusue, Tomokazu; Okamoto, Atsushi; Hosaka, Yoshitaka; Matsumoto, Miwa; Ohnishi, Shuhei; Mochizuki, Hidenori [Chemical and Pharmaceutical Bulletin, 2002, vol. 50, # 9, p. 1187 - 1194]
  • 11
  • 4-(aminomethyl)-1-(phenylmethyl)-4-piperidine-methanol [ No CAS ]
  • [ 493026-47-4 ]
YieldReaction ConditionsOperation in experiment
Multi-step reaction with 2 steps 1: 91 percent / aq. NaOH / dioxane / 1.5 h / 60 °C 2: 39 percent / H2 / 10 percent Pd/C / ethanol; CH2Cl2 / 48 h / 20 °C
Reference： [1]Nishida, Hidemitsu; Miyazaki, Yutaka; Mukaihira, Takafumi; Saitoh, Fumihiko; Fukui, Miyuki; Harada, Kousuke; Itoh, Manabu; Muraoka, Aki; Matsusue, Tomokazu; Okamoto, Atsushi; Hosaka, Yoshitaka; Matsumoto, Miwa; Ohnishi, Shuhei; Mochizuki, Hidenori [Chemical and Pharmaceutical Bulletin, 2002, vol. 50, # 9, p. 1187 - 1194]
  • 12
  • 2-amino-3-chloro-pyridine-4-thiol [ No CAS ]
  • 6-chloropyrido[2,3-b]pyrazin-2-yl trifluoromethanesulfonate [ No CAS ]
  • [ 493026-47-4 ]
  • tert-butyl ((1-(6-((2-amino-3-chloropyridin-4-yl)thio)pyrido[2,3-b]pyrazin-2-yl)-4-(hydroxymethyl)piperidin-4-yl)methyl)carbamate [ No CAS ]
YieldReaction ConditionsOperation in experiment
44% Stage #1: 6-chloropyrido[2,3-b]pyrazin-2-yl trifluoromethanesulfonate; [[4-hydroxymethyl-4-piperidinyl]methyl]carbamic acid 1,1-dimethylethyl ester With N-ethyl-N,N-diisopropylamine In N,N-dimethyl acetamide at 0 - 20℃; for 2h; Stage #2: 2-amino-3-chloro-pyridine-4-thiol With N-ethyl-N,N-diisopropylamine In 1,4-dioxane; N,N-dimethyl acetamide at 100℃; for 16h; 86.A Step A: tert-Butyl ([4-(hydroxymethyl)-4-piperidinyl]methyl)carbamate (0.19 g, 0.77 mmol) and Hunig's base (0.40 mL, 2.3 mmol) were added to a solution of 6- chloropyrido[2,3-b]pyrazin-2-yl trifluoromethanesulfonate (0.24 g, 0.77 mmol) in DMA cooled to 0 °C, and the reaction was stirred while warming to room temperature over 2 hours. The reaction was poured into water and extracted into EtOAc, and the layers were separated. The organics were washed with water, brine, dried over MgSO4 and concentrated in vacuo. The residue was chromatographed using 0-100% EtOAc/DCM as eluent to give a solid. The solid was taken up in dioxanes (10 mL) and DMA (2 mL), followed by addition of 2-amino- 3-chloropyridine-4-thiol (0.37 g, 2.3 mmol) and Hunig's base (0.40 mL, 2.3 mmol). The reaction was heated to 100 °C for 16 hours. The reaction was poured into water, and the aqueous layer was extracted into EtOAc. The layers were separated. The organics were washed with water, brine, dried over MgSO4 and concentrated in vacuo. The material was chromatographed using 50-100% EtOAc/DCM as eluent to give tert-butyl ((1-(6-((2-amino-3- chloropyridin-4-yl)thio)pyrido[2,3-b]pyrazin-2-yl)-4-(hydroxymethyl)piperidin-4- yl)methyl)carbamate (0.18 g, 44% yield).
Reference： [1]Current Patent Assignee: ARRAY BIOPHARMACEUTICAL; PFIZER INC - WO2020/81848, 2020, A1 Location in patent: Paragraph 00465

Tags: 493026-47-4 synthesis path| 493026-47-4 SDS| 493026-47-4 COA| 493026-47-4 purity| 493026-47-4 application| 493026-47-4 NMR| 493026-47-4 COA| 493026-47-4 structure

Same Skeleton Products
Related Products
Categories
Chemistry
Heterocyclic Building Blocks
Piperidines
Chemistry
Organic Building Blocks
Amines
Chemistry
Organic Building Blocks
Amides
Chemistry
Organic Building Blocks
Alcohols
Chemistry
Heterocyclic Building Blocks
Aliphatic Heterocycles
Historical Records